AU2001248177A1 - Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof - Google Patents

Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof

Info

Publication number
AU2001248177A1
AU2001248177A1 AU2001248177A AU4817701A AU2001248177A1 AU 2001248177 A1 AU2001248177 A1 AU 2001248177A1 AU 2001248177 A AU2001248177 A AU 2001248177A AU 4817701 A AU4817701 A AU 4817701A AU 2001248177 A1 AU2001248177 A1 AU 2001248177A1
Authority
AU
Australia
Prior art keywords
chlamydia
antigen
heavy chain
dna fragments
corresponding dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248177A
Inventor
Pamela Dunn
Andrew D. Murdin
Raymond P Oomen
Joe Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
AVENTIS PASTEUR
Aventis Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AVENTIS PASTEUR, Aventis Pasteur Ltd filed Critical AVENTIS PASTEUR
Publication of AU2001248177A1 publication Critical patent/AU2001248177A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001248177A 2000-04-04 2001-04-04 Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof Abandoned AU2001248177A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19447500P 2000-04-04 2000-04-04
US60/194,475 2000-04-04
PCT/CA2001/000461 WO2001075113A2 (en) 2000-04-04 2001-04-04 Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof

Publications (1)

Publication Number Publication Date
AU2001248177A1 true AU2001248177A1 (en) 2001-10-15

Family

ID=22717743

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248177A Abandoned AU2001248177A1 (en) 2000-04-04 2001-04-04 Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof

Country Status (3)

Country Link
US (1) US20020132994A1 (en)
AU (1) AU2001248177A1 (en)
WO (1) WO2001075113A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3790900A (en) 1998-12-01 2000-06-19 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1169465B1 (en) * 1998-12-04 2006-03-01 University Of Manitoba Two-step immunization procedure against chlamydia infection
US7297341B1 (en) 1998-12-23 2007-11-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
JP2003512017A (en) 1998-12-23 2003-04-02 アベンティス、パストゥール、リミテッド Chlamydia antigens and corresponding DNA fragments and uses thereof
US6808713B1 (en) 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
AU775695B2 (en) * 1999-03-12 2004-08-12 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
CA2373021A1 (en) * 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
JP4667694B2 (en) * 1999-09-20 2011-04-13 サノフィ、パストゥール、リミテッド Chlamydia antigen and corresponding DNA fragments and uses thereof
EP1240331B1 (en) * 1999-12-22 2010-04-07 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US20020082402A1 (en) * 2000-04-04 2002-06-27 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US20040254130A1 (en) * 2000-05-08 2004-12-16 Murdin Andrew D Chlamydia antigens and corresponding dna fragments and uses thereof
EP1297005B1 (en) * 2000-07-03 2009-08-26 Novartis Vaccines and Diagnostics S.r.l. Immunisation against chlamydia pneumoniae
US20080112965A1 (en) * 2001-10-01 2008-05-15 Aventis Pasteur Limited Chlamydia OMP antigen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9814878A (en) * 1997-11-21 2000-10-03 Genset Sa Genetic sequence and polypeptides of chlamydia pneumoniae, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
KR100735651B1 (en) * 1997-11-28 2007-07-06 세로노 제네틱스 인스티튜트 에스.에이. Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
EP1297005B1 (en) * 2000-07-03 2009-08-26 Novartis Vaccines and Diagnostics S.r.l. Immunisation against chlamydia pneumoniae

Also Published As

Publication number Publication date
US20020132994A1 (en) 2002-09-19
WO2001075113A2 (en) 2001-10-11
WO2001075113A3 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
AU7398200A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
EP1247815A3 (en) Modified oligonucleotides and uses thereof
AU2001271744A1 (en) Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9
AU2001248177A1 (en) Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof
AU2001238320A1 (en) Microarray methods utilizing semiconductor nanocrystals
AU2002359495A1 (en) Anti-tnf antibodies, compositions, methods and uses
AU2001248172A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU2138501A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU2001248176A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001248171A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001279251A1 (en) Microarray placer unit
AU2001248178A1 (en) Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
AU2001294833A1 (en) Chlamydia pmp proteins, gene sequences and uses thereof
AU2001246703A1 (en) Dna immunization vectors
AU2002359645A1 (en) Targeted genetic risk-stratification using microarrays
AU2001285155A1 (en) Polymorphic dna fragments and uses thereof
AU2138601A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU2002216863A1 (en) Streptococcus pyogenes antigens and corresponding DNA fragments
AU1375501A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU7398400A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU5668500A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
EP1447411A4 (en) Novel protein, its dna and use thereof
AU2002347346A1 (en) Dna vaccine
AU7398700A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU7398600A (en) Chlamydia antigens and corresponding dna fragments and uses thereof